Dopamine receptor interactions: some implications for the treatment of Parkinson's disease.
about
Molecular imaging of movement disordersRotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsDelayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.Dopamine receptor genes: new tools for molecular psychiatry.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.New pharmacotherapy for Parkinson's disease.Lead neurotoxicity: exploring the potential impact of lead substitution in zinc-finger proteins on mental health.Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.The role of dopamine in epilepsy.Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases.Identification of a subpopulation of substantia nigra pars compacta gamma-aminobutyric acid neurons that is regulated by basal ganglia activity.Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones.
P2860
Q28071336-283675FB-B372-4685-BFE4-9C49B33E56ABQ28250152-834EB40C-1F4B-40D0-86BC-12E6FD222B47Q30666545-C19E4735-C1E7-498A-A8CF-52564290D745Q33921096-20F1A6B7-1D33-43B7-B1E3-E7EEC9F74C3AQ35264378-AFCED4DA-52F0-4A75-91A4-FF345C6557C0Q38555723-30E69C88-FF17-4FE8-BF05-6B9B87918E52Q38690294-93E207EE-8A17-4B19-AA02-40CABCBF3D0AQ39360071-AE71ACE4-5EEB-4D49-9E88-9BDA3A4F6640Q41095940-0610872B-FD93-44ED-84E1-ACD286C48B06Q41209277-D7868EC8-2EE5-4F28-9922-3212CF6B17D7Q42480482-7AFE0951-6797-47E3-8297-38E2B7BD7E26Q42515795-42C2000A-1112-4FE0-845B-B77AA9DD271EQ47876389-2606A834-FC8A-44A4-916C-005CD9DFE1B8Q48576589-01CBE37E-64F3-4807-B9EE-F46BF9B03049
P2860
Dopamine receptor interactions: some implications for the treatment of Parkinson's disease.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Dopamine receptor interactions ...... atment of Parkinson's disease.
@ast
Dopamine receptor interactions ...... atment of Parkinson's disease.
@en
type
label
Dopamine receptor interactions ...... atment of Parkinson's disease.
@ast
Dopamine receptor interactions ...... atment of Parkinson's disease.
@en
prefLabel
Dopamine receptor interactions ...... atment of Parkinson's disease.
@ast
Dopamine receptor interactions ...... atment of Parkinson's disease.
@en
P1476
Dopamine receptor interactions ...... atment of Parkinson's disease.
@en
P2093
Robertson HA
P304
P356
10.1016/0166-2236(92)90034-6
P577
1992-06-01T00:00:00Z